PATENT CLAIM ANALYSIS

Application Number: 16254163
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "001890"]

Abstract:
A method for detecting or ruling out renal amyloidosis in a subject is disclosed. The use of a stilbene derivative, such as florbetapir  18 F, or a phenylbenzothiazole derivative in positron emission tomography imaging, or integrated positron emission tomography/computed tomography imaging, can serve as a screening test for renal amyloidosis in a subject.

Claim (Index 4):
The method of  claim 1  wherein:\n step (b) comprises acquiring the image using an imaging method selected from positron emission tomography imaging, positron emission tomography with computed tomography imaging, and positron emission tomography with magnetic resonance imaging.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.59459
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13878689', '15030214', '12064146', '15320112', '15748556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7307378316801099
- 35 USC 102 Novelty (BERT): 0.4839482938769446
- Combined Prediction Score: 0.7060588778997934
- Mean Citation Score: 224.64024
- Max Citation Score: 262.05453
- Similarity Product: 255.1068551827008

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test